- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Head, Public Affairs, Denmark | Copenhagen | Denmark | Corporate Affairs | Audit & Compliance | Communications & Public Affairs | Dec 02, 2025 |
| Government Affairs Manager | Moscow (City) | Russian Fed. | Corporate Affairs | General Management | Communications & Public Affairs | Dec 02, 2025 |
| Director, Public Affairs | New South Wales (NSW) | Australia | Corporate Affairs | General Management | Communications & Public Affairs | Dec 02, 2025 |
| Sr Manager, Executive Communications | Toranomon (NPKK Head Office) | Japan | Corporate Affairs | Communications | Communications & Public Affairs | Dec 02, 2025 |
| Senior Manager, Associate Engagement - Site Communication | Hyderabad (Office) | India | Corporate Affairs | Communications | Communications & Public Affairs | Dec 02, 2025 |
| Medical Representative (CRM - Nigeria-West - Benin) | Ikeja, Lagos | Nigeria | Corporate Affairs | Marketing | Sales | Dec 02, 2025 |
| Field Product Specialist _ Oncology _ HCM | Vietnam | Vietnam | Corporate Affairs | Sales | Sales | Nov 26, 2025 |
| Praktikant*in (m/w/d) im Bereich Corporate Communications mit Start in 2026 | Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) | Germany | Corporate Affairs | Information Technology | Others | Nov 25, 2025 |
| Public Affairs Manager (f/m/d) | Vienna | Austria | Corporate Affairs | Audit & Compliance | Communications & Public Affairs | Nov 12, 2025 |
| Director, Public Affairs | Beijing (Beijing) | China | Corporate Affairs | Corporate & Division Services | Communications & Public Affairs | Nov 11, 2025 |
| Manager, Policy Communications | Washington, DC | USA | Corporate Affairs | Corporate & Division Services | Communications & Public Affairs | Oct 27, 2025 |
| Manager, TA Patient Advocacy | Shanghai (Shanghai) | China | Corporate Affairs | Communications | Communications & Public Affairs | Mar 04, 2025 |
Pagination
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى